The ConvaTec patent covered any salt solution “between 1 per cent and 25 per cent of the total volume of treatment”. However, Smith and Nephew devised a competing product that used 0.77 per cent concentration, bypassing, or so it believed, the ConvaTec patent. A previous judgment in 2013 ruled in Smith & Nephew’s favour because of a mathematical quirk known among chemists as the “significant...